Navigation Links
Terumo Showcases Radial Access Portfolio at American College of Cardiology Conference
Date:3/17/2017

SOMERSET, N.J., March 17, 2017 /PRNewswire/ -- Terumo Interventional Systems will showcase its market-leading portfolio of radial access solutions at the American College of Cardiology (ACC) Annual Scientific Session and Expo in Washington, D.C., March 17-19.   The Terumo booth (#1709) will feature the company's line of high-performance devices specifically designed to enable interventional cardiologists to perform cardiac catheterizations through the radial artery in the wrist.

While the femoral artery in the groin had historically been the standard entry point for most cardiac catheterizations performed in the U.S., adoption of the transradial approach has increased exponentially because it is associated with better patient outcomes and reduction in bleeding complications.  The MATRIX Study, which was presented at the ACC meeting in 2015, compared transradial with transfemoral approaches in 8,404 patients undergoing stenting for treatment of acute coronary syndrome.  The study, which was sponsored by Terumo, found that radial, as compared to femoral access, reduced net adverse clinical events through a reduction in bleeding and all-cause mortality. 

Continue Reading
Terumo offers high-performance devices that enable interventional cardiologists to perform cardiac catheterizations through the radial artery in the wrist, an approach associated with better patient outcomes and reduced bleeding complications.
Terumo offers high-performance devices that enable interventional cardiologists to perform cardiac catheterizations through the radial artery in the wrist, an approach associated with better patient outcomes and reduced bleeding complications.

"The MATRIX study appears to have served as a pivot point for the U.S. interventional community to adopt radial access," said Chris Pearson, Senior VP of Marketing, Terumo Interventional Systems.  "After that, we saw greater demand for our innovative education and training programs Terumo has pioneered in this area.  We're proud of the work we have done in partnership with the medical community to drive utilization of the radial approach.  We look forward to continuing to work together to make radial the preferred approach, especially for sicker patients, which as the MATRIX study showed could benefit greatly."

Adopting radial access can help hospitals to reduce costs by moving patients out of the catheterization laboratory faster and reducing complications and readmissions.  When a transradial approach is used, a significant number of elective PCI patients may be considered for same day discharge from the hospital.  In 2006, Terumo became the first company in the U.S. to offer training and educational programs for radial access.  Today, Terumo uses its deep understanding of the clinical, practical and economic benefits of the technique to help physicians and hospitals achieve success.  More information is available at http://www.terumois.com/procedural-solutions/about-access.html. The Terumo exhibit at ACC will present the company's comprehensive portfolio of sheaths, catheters, and closure devices specifically engineered for radial access, including:

  • GLIDESHEATH® SLENDER Hydrophilic Coated Introducer Sheath intended for smooth atraumatic radial access to minimize the risk of scarring and damage.
  • TR Band® Compression Device designed to assist hemostasis of the radial artery after a transradial procedure.
  • GLIDEWIRE® Hydrophilic Coated Guidewire with a proprietary design for smooth, rapid movement through tortuous vessels and crossability over difficult lesions.  
  • Optitorque® Diagnostic Catheters with radial specific curves designed to enable support and alignment during catheterization.
  • HEARTRAIL® Coronary Guiding Catheters designed to use contralateral wall resulting in enhanced back-up support in comparison to standard femoral guiding catheter shapes.

About Terumo Interventional Systems
Terumo Interventional Systems (TIS), a division of Terumo Medical Corporation, is a market leader in minimally invasive entry site management and lesion access technologies.  TIS offers a comprehensive portfolio of solutions – from access to closure – that deliver clinical value, economic benefit and enhanced patient outcomes regardless of the site that is used to access the vascular system.  TIS combines innovative research and development with a deep market understanding to create a pipeline of industry leading devices that are used in advanced coronary, peripheral endovascular and urological treatments.  The complete TIS product portfolio includes guidewires, catheters, sheaths, peripheral stents, embolics, and closure devices for both transfemoral and transradial approaches.   For more information, visit www.terumois.com

About Terumo Business Edge
Terumo Business Edge, a business unit of Terumo Medical Corporation, is a consulting group with specific expertise and experience in helping identify operational and administrative process improvements in the Cardiac Cath Lab.  Leveraging the clinical and care pathway advantages of transradial and same day discharge, Terumo Business Edge is helping cath labs define new, more cost-effective care pathways.  For more information, visit www.terumobusinessedge.com.

About Terumo Medical Corporation
Founded in 1972 as a Terumo Corporation subsidiary, Terumo Medical Corporation (TMC) develops, manufactures, and markets high-quality medical devices used in a broad range of applications in numerous healthcare markets.  TMC boasts 716 employees in the United States and is structured with three main business divisions including Terumo Interventional Systems, Terumo Medical Products, and Terumo Pharmaceutical Solutions.  TMC manufactures a broad portfolio of safety needles and syringes, safety peripheral IV catheters, entry-site management products, and a line of blood collection products used in hospitals and blood banks worldwide. 

About Terumo Corporation
Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with over $5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. Terumo contributes to society by providing valued products and services to the health care market and by responding to the needs of health care providers and the people they serve. Terumo Corporation's shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan's leading stock index.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/terumo-showcases-radial-access-portfolio-at-american-college-of-cardiology-conference-300425335.html


'/>"/>
SOURCE Terumo Medical Corporation
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Research and Markets - Global Intravenous (IV) Solutions Market Analysis 2016 - Forecast to 2022 - Key Players are Widatra Bhakti, Vifor Pharma & Terumo
2. Terumo BCT Announces a $17.4 Million Funding Contract from the Biomedical Advanced Research and Development Authority (BARDA)
3. Global Coronary Artery Disease Treatment Devices Market 2015-2019 - Key Vendors are Abbott Vascular, Boston Scientific, Medtronic & Terumo
4. MC3 Cardiopulmonary Acquires Surgical Cannula Product Assets from Terumo Cardiovascular Systems
5. Abiomed Inc., HeartWare International and Terumo Corporation Battling out for the top Spot in the Cardiac Assist Devices Market
6. OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo Corporation
7. Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating
8. Global Coronary Stents Market 2014-2018: Key Vendors are Abbott, Boston Scientific, Medtronic and Terumo
9. Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp.
10. ExcipientFest Americas Showcases Pharma and Biotech Breakthroughs
11. Bracco Showcases Its Commitment to Diagnostic Imaging to Improve Patient Care and Clinical Outcomes at the 2016 Radiological Society of North America Annual Meeting (RSNA)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... The National University of Singapore (NUS) ... company, signed a Memorandum of Understanding (MOU) recently ... the region. Under this MOU, ... Technology (BIGHEART) at NUS and Holmusk will establish ... healthcare IT and medical device development. These include ...
(Date:3/27/2017)... , March 27, 2017  A recent study ... only four freestanding hospitals in the country dedicated to ... and reconstructive surgery, concluded that the Surfacide Helios ® ... integral component in reducing bacterial pathogens not killed by ... were published at the American Burn Association,s 49th Annual ...
(Date:3/27/2017)... Germany , March 27, 2017 ... over 7,000 attendees and more than 600 exhibitors ... and discover opportunities and solutions that will advance ... 6 April 2017 at the Messe Stuttgart, ... the preeminent medical technology platform showcasing the key ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... 2017 , ... The Radiology Business Management Association (RBMA) is pleased ... new executive director. Mr. Still was selected through a careful months-long search by the ... is known to our members, has been a part of building the RBMA since ...
(Date:3/28/2017)... ... 28, 2017 , ... Neurotechnology , a provider of ... attendance tracking products: the new NCheck Cloud Bio Attendance cloud-based service and the ... face recognition to enable users to check in and out from anywhere via ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Executives, Staff & ... money to for the Toys for Tots Literacy Campaign at their Semi-Annual Graduation and ... of $70 billion, the U.S. ranks at number 14 internationally in literacy. Statistically, a ...
(Date:3/28/2017)... ... March 28, 2017 , ... Prominant bariatric surgeon and ... thrilled to offer the recently FDA-approved Obalon Balloon System to his patients. The ... Advanced Surgical’s already comprehensive list of weight-loss services. Dr. Liu is proud ...
(Date:3/28/2017)... ... 2017 , ... Silicon Valley Hair Institute, the San Francisco Bay Area leader ... women’s hair loss. Although hair transplant procedures can be seen as more of a ... can be two reasons a woman may see her hair thinning. , “We are ...
Breaking Medicine News(10 mins):